| 000 | 01743 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516225755.0 | ||
| 264 | 0 | _c20160325 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1573-2665 | ||
| 024 | 7 |
_a10.1007/s10545-014-9751-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Meijden, J C | |
| 245 | 0 | 0 |
_aTen years of the international Pompe survey: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease. _h[electronic resource] |
| 260 |
_bJournal of inherited metabolic disease _cMay 2015 |
||
| 300 |
_a495-503 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEnzyme Replacement Therapy _xmethods |
| 650 | 0 | 4 | _aFatigue |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycogen Storage Disease Type II _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Outcome Assessment |
| 650 | 0 | 4 | _aPatient Participation |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSelf Report |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_aalpha-Glucosidases _xtherapeutic use |
| 700 | 1 | _aGüngör, D | |
| 700 | 1 | _aKruijshaar, M E | |
| 700 | 1 | _aMuir, A D J | |
| 700 | 1 | _aBroekgaarden, H A | |
| 700 | 1 | _avan der Ploeg, A T | |
| 773 | 0 |
_tJournal of inherited metabolic disease _gvol. 38 _gno. 3 _gp. 495-503 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10545-014-9751-2 _zAvailable from publisher's website |
| 999 |
_c24088005 _d24088005 |
||